Teva Pharmaceutical Industries Ltd (TEVA)
17.08
+0.06
(+0.32%)
USD |
NYSE |
Nov 21, 16:00
17.08
0.00 (0.00%)
After-Hours: 19:53
Teva Pharmaceutical Industries Enterprise Value: 35.28B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 35.28B |
| November 19, 2024 | 35.03B |
| November 18, 2024 | 34.66B |
| November 15, 2024 | 34.60B |
| November 14, 2024 | 34.96B |
| November 13, 2024 | 35.17B |
| November 12, 2024 | 35.37B |
| November 11, 2024 | 35.66B |
| November 08, 2024 | 35.37B |
| November 07, 2024 | 35.81B |
| November 06, 2024 | 35.73B |
| November 05, 2024 | 37.25B |
| November 04, 2024 | 37.10B |
| November 01, 2024 | 36.88B |
| October 31, 2024 | 36.87B |
| October 30, 2024 | 37.04B |
| October 29, 2024 | 36.86B |
| October 28, 2024 | 36.79B |
| October 25, 2024 | 36.26B |
| October 24, 2024 | 36.66B |
| October 23, 2024 | 36.84B |
| October 22, 2024 | 36.81B |
| October 21, 2024 | 36.58B |
| October 18, 2024 | 36.32B |
| October 17, 2024 | 36.33B |
| Date | Value |
|---|---|
| October 16, 2024 | 36.40B |
| October 15, 2024 | 36.54B |
| October 14, 2024 | 35.51B |
| October 11, 2024 | 35.53B |
| October 10, 2024 | 35.71B |
| October 09, 2024 | 36.07B |
| October 08, 2024 | 35.84B |
| October 07, 2024 | 35.56B |
| October 04, 2024 | 35.80B |
| October 03, 2024 | 35.67B |
| October 02, 2024 | 35.76B |
| October 01, 2024 | 36.00B |
| September 30, 2024 | 36.40B |
| September 27, 2024 | 36.37B |
| September 26, 2024 | 36.68B |
| September 25, 2024 | 36.37B |
| September 24, 2024 | 36.67B |
| September 23, 2024 | 36.66B |
| September 20, 2024 | 36.42B |
| September 19, 2024 | 36.71B |
| September 18, 2024 | 36.84B |
| September 17, 2024 | 36.81B |
| September 16, 2024 | 37.06B |
| September 13, 2024 | 37.44B |
| September 12, 2024 | 36.99B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
27.05B
Minimum
Jul 03 2023
40.71B
Maximum
Feb 12 2020
33.21B
Average
33.09B
Median
Enterprise Value Benchmarks
| Amicus Therapeutics Inc | 3.005B |
| Compugen Ltd | 15.33M |
| Pluri Inc | 33.05M |
| Can Fite Biofarma Ltd | 7.526M |
| BiomX Inc | 4.360M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -437.00M |
| Revenue (Quarterly) | 4.331B |
| Total Expenses (Quarterly) | 3.347B |
| EPS Diluted (Quarterly) | -0.39 |
| Gross Profit Margin (Quarterly) | 49.60% |
| Profit Margin (Quarterly) | -10.09% |
| Earnings Yield | -4.98% |
| Operating Earnings Yield | 19.36% |
| Normalized Earnings Yield | 9.002 |